Extracolonic findings observed on computed tomography colonography scans of cancer patients might identify undetected malignancies more often than previously thought, according to a new study in Clinical Imaging. 

The research focused on a radiopharmaceutical that contains the isotope zirconium 89, which has a significantly longer half-life compared to gallium-68-labelled PSMA ligands.

The study's findings could be used to help clinicians guide treatment decisions for CRC patients, experts suggested in Academic Radiology.

In clinical trials, the therapy reduced patients' risk of death by 38%, along with significantly decreasing disease progression. 

Use of such agents has diminished in recent years, but there is still a great need for oral contrast among oncology patients, experts report in AJR. 

Doctors created a simple system that categorizes adnexal lesions as classic or nonclassic to streamline the process of ovarian cancer risk stratification.

Scientists involved in the study believe the innovative technology has exciting potential to improve screening, prognosis and treatment, according to research published in Scientific Reports. 

CT surveillance is the standard of care for postoperatively monitoring testicular cancer, but when patients must undergo scans every few months after surgery, accumulative radiation exposure becomes a concern.